Document is current
Any future updates will be listed below
-
Authors
Fujiwara, Masaki
Yamada, Yuto
Etoh, Tsuyoshi
Shimazu, Taichi
Kodama, Masafumi
Yamada, Norihito
Asada, Takahiro
Horii, Shigeo
Kobayashi, Takafumi
Hayashi, Teruo
Ehara, Yoshitaka
Fukuda, Kenji
Harada, Keita
Fujimori, Maiko
Odawara, Miyuki
Takahashi, Hirokazu
Hinotsu, Shiro
Nakaya, Naoki
Uchitomi, Yosuke
Inagaki, Masatoshi http://orcid.org/0000-0002-9822-8649
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (21EA1013, 23EA1031)
- License Information
-
More Information
Article History
Received: 8 August 2023
Accepted: 17 December 2023
First Online: 4 January 2024
Declarations
:
: The study was approved by the institutional ethics committee of Okayama University (RIN2202-002). Consent to participate in the study was obtained from the director and the implementation team member at each participating hospital.
: Not applicable.
: M. F.<sup>1</sup> has received honoraria for lectures from Mochida. Y. Y. has received honoraria for lectures from Meiji, Sumitomo Pharma, and Lundbeck. N. Y. has received grants from Eisai and Otsuka and has received honoraria for lectures from Eisai, Otsuka, Takeda, MSD, UCB, Viatris, Sumitomo Pharma, and Meiji. M. I. has received grants from Astellas, Eisai, Otsuka, Shionogi, Daiichi Sankyo, Sumitomo Pharma, Takeda, Mitsubishi Tanabe Pharma, Nihon Medi-Physics, Pfizer, Fujifilm, and Mochida and has received honoraria for lectures from EA Pharma, Meiji, MSD, Viatris, Eisai, Otsuka, Sumitomo Pharma, Takeda, Eli Lilly, Nippon Shinyaku, Pfizer, Mochida, Janssen, and Yoshitomiyakuhin. The other authors declare that they have no competing interests.
